Veradermics

(NYSE) MANE

Current Price$101.38

Market Cap$4.25B

Since IPO (2026)+169%

5 YearN/A

1 YearN/A

1 Month+45%

Veradermics Financials at a Glance

Market Cap

$4.25B

Revenue (TTM)

$0.00

Net Income (TTM)

$67.14

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-1.31 (Low)

Dividend

$0.00

Beta (Volatility)

-1.31 (Low)

Price

$101.38

Volume

278,732

Open

$106.92

Price

$101.38

Volume

278,732

Open

$106.92

Previous Close

$101.62

Daily Range

$101.11 - $107.00

52-Week Range

$17.00 - $117.71

Dividend

$0.00

Beta (Volatility)

-1.31 (Low)

Price

$101.38

Volume

278,732

Open

$106.92

Previous Close

$101.62

Daily Range

$101.11 - $107.00

52-Week Range

$17.00 - $117.71

MANE News

This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO

Jonathan PoncianoMay 14, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Veradermics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Reid Waldman, MD

Website

www.veradermics.com

Headquarters

New Haven, CT 06513, US

MANE Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-15%

Return on Assets

-14%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.25B

Shares Outstanding

41.78M

Volume

278.73K

Avg. Volume

524.06K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$72.35M

EBITDA

$70.00M

Operating Cash Flow

$71.60M

Capital Expenditure

$24.00K

Free Cash Flow

$71.63M

Cash & ST Invst.

$141.86M

Total Debt

$4.00K

Veradermics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.25B

N/A

Market Cap/Employee

$202.17M

N/A

Employees

N/A

Net Income

$27.23M

N/A

EBITDA

$29.86M

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$390.80M

N/A

Accounts Receivable

$1.65M

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-13.73%

N/A

Return on Invested Capital

-15.02%

N/A

Free Cash Flow

$21.17M

N/A

Operating Cash Flow

$21.17M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TVTXTravere Therapeutics, Inc.

TVTXTravere Therapeutics, Inc.$44.43-0.69%

OVIDOvid Therapeutics Inc.

OVIDOvid Therapeutics Inc.$2.47+1.23%

ABEOAbeona Therapeutics Inc.

ABEOAbeona Therapeutics Inc.$5.44-1.45%

HELPCybin Inc. Common Stock

HELPCybin Inc. Common Stock$4.68+1.74%

PLYXPolaryx Therapeutics, Inc. Common Stock

PLYXPolaryx Therapeutics, Inc. Common Stock$3.60-8.63%

LSTALisata Therapeutics, Inc.

LSTALisata Therapeutics, Inc.$3.14+0.00%

XTLBXTL Biopharmaceuticals Ltd.

XTLBXTL Biopharmaceuticals Ltd.$2.51-1.18%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

ACHRArcher Aviation

ACHRArcher Aviation$6.36+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

Questions About MANE

What is the current price of Veradermics?

Veradermics is trading at $101.62 per share.

What is the 52-week range for Veradermics?

Over the past 52 weeks, Veradermics has traded between $17.00 and $117.71.

How much debt does Veradermics have?

As of the most recent reporting period, Veradermics reported total debt of N/A.

How much cash does Veradermics have on hand?

Veradermics reported $168.41M in cash and cash equivalents in its most recent financial results.

What is Veradermics’s dividend yield?

Veradermics does not currently have a dividend yield.

Veradermics

Veradermics Financials at a Glance

MANE News

This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Veradermics

MANE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Veradermics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MANE

What is the current price of Veradermics?

What is the 52-week range for Veradermics?

How much debt does Veradermics have?

How much cash does Veradermics have on hand?

What is Veradermics’s dividend yield?

Premium Investing Services